US2012238475A1PendingUtilityA1

Methods of Amplifying and Sequencing Nucleic Acids

59
Assignee: LEAMON JOHN HPriority: Jan 29, 2003Filed: Mar 13, 2012Published: Sep 20, 2012
Est. expiryJan 29, 2023(expired)· nominal 20-yr term from priority
B01L 3/502707C07H 21/00C12Q 1/6834C12Q 1/686C12Q 1/6867B01L 2300/0877C12N 15/1093C12Q 1/6865G01N 2021/6484B01L 7/52C12Q 1/6806B01L 2300/0819Y10T436/143333B01L 3/502715B01L 3/5085Y02P20/582B01L 3/5027G01N 21/6458G01N 21/6452B01L 2300/0636G01N 21/253C12Q 1/6869G01R 33/1269C12N 15/1075C12Q 1/6844C12Q 1/6874G01N 21/6428
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An apparatus and method for performing rapid DNA sequencing, such as genomic sequencing, is provided herein. The method includes the steps of preparing a sample DNA for genomic sequencing, amplifying the prepared DNA in a representative manner, and performing multiple sequencing reaction on the amplified DNA with only one primer hybridization step.

Claims

exact text as granted — not AI-modified
1 ) A system for sequencing nucleic acids, comprising:
 a perfusion chamber comprising an upper side and an array of at least 10,000 reaction chambers a plurality of which comprise a bead each with multiple clonal copies of a species of nucleic acid immobilized thereon, wherein the sealed perfusion chamber further comprises a first port detachably coupled to a fluidics subsystem that comprises a single inlet conduit operatively coupled to a manifold, and an A nucleotide tube, a G nucleotide tube, a T nucleotide tube, and a C nucleotide tube.   
     
     
         2 ) The system of  claim 1 , wherein:
 the perfusion chamber further comprises a second port to withdraw reagents and reaction products.   
     
     
         3 ) The system of  claim 1 , wherein:
 the multiple clonal copies comprise at least 100,000 copies.   
     
     
         4 ) The system of  claim 1 , wherein:
 the inlet conduit utilizes a pressurized system to drive a positive flow of fluids through the sealed perfusion chamber.   
     
     
         5 ) The system of  claim 4 , wherein:
 the positive flow comprises a flow rate in a range from 0.5 to 50 ml/min.   
     
     
         6 ) The system of  claim 1 , wherein:
 the manifold further comprises a wash tube.   
     
     
         7 ) The system of  claim 1 , wherein:
 the manifold further comprises a polymerase tube.   
     
     
         8 ) The system of  claim 1 , wherein:
 the perfusion chamber comprises a plastic housing positioned over the array of reaction chambers.   
     
     
         9 ) The system of  claim 1 , wherein:
 the upper side of the perfusion chamber is transparent.   
     
     
         10 ) The system of  claim 1 , wherein:
 the perfusion chamber is sealed.   
     
     
         11 ) The system of  claim 1 , wherein:
 the perfusion chamber comprises a ceiling positioned about 300 μm over the array of reaction chambers.   
     
     
         12 ) The system of  claim 1 , wherein:
 the reaction chambers are circular, cylindrical, or multisided.   
     
     
         13 ) The system of  claim 12 , wherein:
 the multisided reaction chambers are hexagonal.   
     
     
         14 ) The system of  claim 1 , wherein:
 the reaction chambers comprise a smooth wall surface and a planar bottom surface.   
     
     
         15 ) The system of  claim 1 , wherein:
 the clonal copies of the species of nucleic acid are immobilized on the bead by a covalent linkage.   
     
     
         16 ) The system of  claim 1 , wherein:
 the clonal copies of the species of nucleic acid comprise an oligonucleotide primer covalently linked to the bead and a complimentary copy of a template nucleic acid extended therefrom.   
     
     
         17 ) The system of  claim 1 , wherein:
 the clonal copies of the species of nucleic acid comprise a detectable sequence tag associated with a biological source.   
     
     
         18 ) The system of  claim 1 , wherein:
 the bead comprises an agarose, acrylamide, or polyacrylamide material.   
     
     
         19 ) The system of  claim 1 , wherein:
 the array comprises a surface coating that comprises a self-assembled monolayer or a metal layer.   
     
     
         20 ) The system of  claim 1 , wherein:
 the array comprises a surface coating that increases the stability of linked macromolecules.   
     
     
         21 ) The system of  claim 1 , wherein:
 the array comprises a surface coating that minimizes absorption of macromolecules.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.